Israeli device company IceCure Medical has chosen Cleveland to be its U.S. headquarters, a move the company’s CEO hinted at in February.
The company plans to open its U.S. headquarters at the Cleveland Clinic-led Global Cardiovascular Innovation Center campus on June 1, according to a statement from IceCure.
The Israeli company has been connected to Northeast Ohio for a few years as a result of its business relationship with the Bridge Investment Fund, which has invested more than $1 million in IceCure since 2008.
“The unique infrastructure for growing biomedical companies, the support we received from many organizations, and the progressive healthcare environment that includes world-class institutions such as the Cleveland Clinic and University Hospitals Case Medical Center, led us to choose Cleveland for our U.S. operations,” said IceCure CEO Hezi Himelfarb, in the statement.
Read more at MedCityNews.com.